Diabetes

Focus on Your Vision follows Dr. Ryo Kubota’s quest to unlock the science behind new ways to treat dry AMD, dry eye and other eye diseases and restore and protect the vision of countless patients suffering from these conditions. Join the conversation as he shares his story, his vision and his knowledge of eye diseases and along the way highlights the promising treatments of tomorrow. Please send your questions or feedback to Dr. Ryo on the Contact page.

One of Dr. Ryo Kubota’s primary focus areas of research at Acucela is dry age-related macular degeneration, or “dry AMD.” This eye disease affects more than 26 million people worldwide and is the leading cause of blindness in people over age 50. Still, there is no cure or currently approved treatment for dry AMD. Acucela is also working on a treatment for dry eye, which has more than 10 million sufferers in the U.S. alone. Learn more about Acucela’s approach to combating AMD.